Park et al., 2012 - Google Patents
State‐of‐the‐art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapyPark et al., 2012
- Document ID
- 17738288974216638137
- Author
- Park S
- Kushwaha S
- McGregor C
- Publication year
- Publication venue
- Clinical Pharmacology & Therapeutics
External Links
Snippet
Congestive heart failure is associated with poor quality of life (QoL) and low survival rates. The development of state‐of‐the‐art cardiac devices holds promise for improved therapy in patients with heart failure. The field of implantable cardiac assist devices is changing rapidly …
- 206010007554 Cardiac failure 0 title abstract description 24
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/10—Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Birks et al. | Prospective multicenter study of myocardial recovery using left ventricular assist devices (RESTAGE-HF [remission from stage D heart failure]) medium-term and primary end point results | |
Goldstein et al. | Third annual report from the ISHLT mechanically assisted circulatory support registry: a comparison of centrifugal and axial continuous-flow left ventricular assist devices | |
Robertson et al. | Concomitant aortic valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: an INTERMACS database analysis | |
Cook et al. | The total artificial heart | |
Shehab et al. | Long-term biventricular HeartWare ventricular assist device support—case series of right atrial and right ventricular implantation outcomes | |
Patel et al. | A contemporary review of mechanical circulatory support | |
Esmore et al. | A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy | |
Maltais et al. | Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices | |
Rajagopal et al. | Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation | |
Takeda et al. | Long-term outcome of patients on continuous-flow left ventricular assist device support | |
Park et al. | State‐of‐the‐art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy | |
Yoshioka et al. | Contemporary outcome of unplanned right ventricular assist device for severe right heart failure after continuous-flow left ventricular assist device insertion | |
De Rita et al. | Mechanical cardiac support in children with congenital heart disease with intention to bridge to heart transplantation | |
Weymann et al. | Gender differences in continuous‐flow left ventricular assist device therapy as a bridge to transplantation: a risk‐adjusted comparison using a propensity score‐matching analysis | |
Ljajikj et al. | Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies | |
Sheikh et al. | HeartMate® II continuous-flow left ventricular assist system | |
Sileshi et al. | Outcomes of patients implanted using a left thoracotomy technique for a miniaturized centrifugal continuous-flow pump | |
Terzi | Mechanical circulatory support: 60 years of evolving knowledge | |
Michel et al. | Bridging patients in cardiogenic shock with a paracorporeal pulsatile biventricular assist device to heart transplantation—a single-centre experience | |
Garascia et al. | Advanced heart failure: from definitions to therapeutic options | |
Zubarevich et al. | Early experience with the Impella pump: single‐center registry | |
Shreenivas et al. | Mechanical circulatory support as a bridge to transplant or for destination therapy | |
Guidetti et al. | Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support: What Does the Future Hold? | |
Grosman-Rimon et al. | The physiological rationale for incorporating pulsatility in continuous-flow left ventricular assist devices | |
Simon et al. | Current and future considerations in the use of mechanical circulatory support devices: An update, 2008–2018 |